Acid suppressive agents and risk of Mycobacterium Tuberculosis: case-control study

作者:Hsu Wen Hung; Kuo Chao Hung; Wang Sophie S W; Lu Chien Yu; Liu Chung Jung; Chuah Seng Kee; Kuo Fu Chen; Chen Yen Hsu; Huang Yaw Bin; Hou Ming Feng; Wu Deng Chyang; Hu Huang Ming*
来源:BMC Gastroenterology, 2014, 14(1): 91.
DOI:10.1186/1471-230X-14-91

摘要

Background: The acid-suppressive agents have been linked with an increased risk of infectious disease. The relationship between these drugs and Mycobacterium Tuberculosis (TB) was not been reported. %26lt;br%26gt;Methods: We conducted a case-control study using data from National Health Insurance research database of Taiwan. From 1996 till 2008, and 6541 cases were defined as TB infection/activation (ICD-9 coding plus prescription two of four first-line anti-TB regimen for at least one month). Control subjects who were matched to the TB cases by age and sex were selected with 10: 1 ratio. Medical records including acid-suppressive agent prescription and comorbidity, and socioeconomic status were analyzed. %26lt;br%26gt;Results: TB infection/activation was more frequent to comorbidity with chronic diseases, alcohol abuse, malignancy, immune deficient/suppression status and acid-related disease (peptic ulcer, reflux esophagitis). Among the TB cases, there was higher exposure record to acid-suppressive agents within 3 months before TB index date (OR 2.43(2.06-2.88) and 1.90 (1.68-2.14) for proton pump inhibitor (PPI) and histamine 2 receptor antagonist (H(2)RA) respectively). After adjusting confounding factors, PPIs prescription 3 months before TB index date had an association of TB infection/activation (adjusted OR 1.63(1.61-1.63)). Similar result was found in H2RA user (adjusted OR 1.51(1.50-1.52)). The association of acid-suppressive agents in TB infection/activation was fade gradually when the drug prescription period extended. %26lt;br%26gt;Conclusions: Recent prescription of acid-suppressive agent seems to associate the TB infection/activation. In the society where TB was prevalent, evaluation of pulmonary TB before prescription of PPI or H2RA is warranted.

  • 出版日期2014-5-13
  • 单位长春大学